MedTrace Logo

Evaluating the Role of the Guidewire in Peripheral Intravenous Access

NCT04949854 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-09-18

No results posted yet for this study

Summary

This study is to demonstrate that the control ultralong intravenous catheter without the guide wire is equivalent to the experimental catheter with the guide wire. The hypothesis of this study is that the 6.35 cm 20G ultralong Ultrasound Guided Peripheral Intravenous (USPIV) will have no difference in survival compared to the 5.71 cm ultralong with wire USPIV.

Conditions

  • Peripheral Intravenous Vein Catheter Phlebitis
  • Intravenous Infection

Interventions

DEVICE

B.Braun 6.35 cm 20 Gauge ultralong intravenous catheter

control Arm 1 (6.35 cm 20 Gauge ultralong intravenous catheter without guidewire

DEVICE

B.D Accucath 5.71 cm 20 Gauge ultralong intravenous catheter

Experimental Arm B.D Accucath 5.71 cm 20 Gauge ultralong intravenous catheter with guide wire

Sponsors & Collaborators

  • William Beaumont Hospitals

    lead OTHER

Principal Investigators

  • Amit Bahl, MD. · William Beaumont Hospitals

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-31
Primary Completion
2023-12-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04949854 on ClinicalTrials.gov